New tool aims to give older leukemia patients a stronger voice in treatment choices
NCT ID NCT04625413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a communication tool called UR-GOAL in 15 older adults (age 60+) with newly diagnosed acute myeloid leukemia (AML), along with their caregivers and doctors. The tool helps patients share their preferences and goals, so treatment decisions better match what matters most to them. The study focused on whether the tool is usable and helpful, not on curing the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UR-GOAL communication tool (a behavioral intervention using conjoint analysis to elicit patient preferences)
What this could lead to
If successful, this tool could help older AML patients and their doctors make more informed, preference-aligned treatment decisions.
What could go wrong
This is a very small pilot study with only 15 participants, so results may not apply broadly. The tool's impact on actual health outcomes is not yet tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester Medical Center
Rochester, New York, 14623, United States